‘The Biggest Monster’ Is Spreading. And It’s Not the Coronavirus. Tuberculosis kills 1.5 million people each year. Lockdowns and supply-chain disruptions threaten progress against the disease as well as H.I.V. and malaria. It begins with a mild fever and malaise, followed by a painful cough and shortness of breath. The infection prospers in crowds, spreading...
Tag: <span>Diagnostic</span>
Study pinpoints women who benefit less from 3D mammograms
Digital breast tomosynthesis improves cancer detection and reduces recalls, but women with extremely dense breasts don’t fully realize that advantage. UNIVERSITY OF WASHINGTON HEALTH SCIENCES/UW MEDICINE A RADIOLOGY TECHNICIAN HELPS PREPARE A PATIENT FOR A SCREENING MAMMOGRAPHY AT UW MEDICAL CENTER-ROOSEVELT IN SEATTLE, WASHINGTON. view more CREDIT: UW MEDICINE A new comparison of two breast-screening...
New system uses X-ray images of patients’ lungs to diagnose COVID-19
Reviewed by James Ives, M.Psych. (Editor) Researchers from the Department of Computer Architecture and Technology at the University of Seville’s School of Computer Engineering (ETSII) are working on a system that uses X-ray images of patients’ lungs to help diagnose COVID-19. This system uses deep learning to train a neural network model that can distinguish...
New 20-Minute Coronavirus Test Can Identify Past and Present Infections: 100 Samples Tested Every Hour
A new coronavirus test can detect past and present COVID-19 infections in just 20 minutes. The Independent reported that blood samples were used by Australian researchers in their newly developed COVID-19 test to determine novel coronavirus infections in 20 minutes; they claimed that is is a world-first breakthrough. Past and Present COVID-19 Infection Can Now...
New infectious disease test accurately diagnoses infection in minutes
by Walter and Eliza Hall Institute of Medical Research Melbourne researchers have developed a fast, new test for infections and infectious diseases that could transform Australia’s ability to provide targeted clinical care and respond to pandemics and biosecurity threats. Called c-FIND, the test has the potential to rapidly and accurately detect multiple viral, bacterial or...
Virginia Tech scientists confirm usually harmless virus attacks the heart’s electrical system
Fralin Biomedical Research Institute scientists show adenovirus disrupts electrical signaling, impedes new communication channels. Credit: Fralin Biomedical Research Institute Adenovirus, which typically can cause a common cold, has a far more dangerous impact if it reaches the heart. When the virus commandeers gap junctions, it can slow production of connexin43, disturbing the electrical system that...
Genomes front and center of rare disease diagnosis
by National Institute for Health Research BioResource A research program pioneering the use of whole-genome sequencing in the NHS has diagnosed hundreds of patients and discovered new genetic causes of disease. Whole genome sequencing is the technology used by the 100,000 Genomes Project, a service set up by the government which aims to introduce routine...
Scientists uncover new genetic mutations linked to autism spectrum disorder
by Sanford Burnham Prebys Medical Discovery Institute Scientists at Sanford Burnham Prebys Medical Discovery Institute and Radboud University Medical Center in the Netherlands have identified mutations in a gene called CNOT1 that affect brain development and impair memory and learning. The study is the first to link neurodevelopmental delays with CNOT1, suggesting that drugs that...
Myriad prostate cancer test wins coverage from Aetna, other insurers
Myriad Genetics on Monday said insurer Aetna and two other health plans have agreed to cover its Prolaris genetic test that measures tumor cell growth to provide an assessment of how quickly a patient’s prostate cancer may progress. BlueCross BlueShield of Tennessee and a third insurer that Myriad did not identify by name will also...
For acute myeloid leukemia, genetic testing is often worth the wait
Study suggests the benefits of a more personalized therapy typically outweigh the risks of delaying treatment to await test results AMERICAN SOCIETY OF HEMATOLOGY PRINT E-MAIL New tailored therapies offer exciting prospects for treating acute myeloid leukemia (AML), but taking advantage of them may require waiting a week or more for genetic testing before starting...